348 related articles for article (PubMed ID: 17516617)
1. Articular damage is associated with intraosseous inflammation in the subchondral bone marrow of joints affected by experimental inflammatory arthritis and is modified by zoledronate treatment.
Bogoch ER; Lee TC; Fornasier VL; Berger SA
J Rheumatol; 2007 Jun; 34(6):1229-40. PubMed ID: 17516617
[TBL] [Abstract][Full Text] [Related]
2. Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis.
Podworny NV; Kandel RA; Renlund RC; Grynpas MD
J Rheumatol; 1999 Sep; 26(9):1972-82. PubMed ID: 10493679
[TBL] [Abstract][Full Text] [Related]
3. Changes in cross-sectional geometry of the distal femoral metaphysis associated with inflammatory arthritis are reduced by a bisphosphonate (zoledronate).
Pysklywec MW; Moran EL; Bogoch ER
J Orthop Res; 2000 Sep; 18(5):734-8. PubMed ID: 11117294
[TBL] [Abstract][Full Text] [Related]
4. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
[TBL] [Abstract][Full Text] [Related]
5. Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis.
Pysklywec MW; Moran EL; Bogoch ER
J Orthop Res; 1997 Nov; 15(6):858-61. PubMed ID: 9497810
[TBL] [Abstract][Full Text] [Related]
6. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
Verdrengh M; Carlsten H; Ohlsson C; Tarkowski A
J Orthop Res; 2007 Mar; 25(3):304-10. PubMed ID: 17089391
[TBL] [Abstract][Full Text] [Related]
7. Pamidronate prevents bone loss associated with carrageenan arthritis by reducing resorptive activity but not recruitment of osteoclasts.
Moran EL; Fornasier TL; Bogoch TR
J Orthop Res; 2000 Nov; 18(6):873-81. PubMed ID: 11192246
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: evaluation of the bone-cartilage interface and subchondral bone marrow.
Appel H; Kuhne M; Spiekermann S; Köhler D; Zacher J; Stein H; Sieper J; Loddenkemper C
Arthritis Rheum; 2006 Jun; 54(6):1805-13. PubMed ID: 16736521
[TBL] [Abstract][Full Text] [Related]
9. Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
Rack B; Jückstock J; Genss EM; Schoberth A; Schindlbeck C; Strobl B; Heinrigs M; Rammel G; Zwingers T; Sommer H; Friese K; Janni W
Anticancer Res; 2010 May; 30(5):1807-13. PubMed ID: 20592383
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the kinetics of osteoclastogenesis in arthritic rats.
Schett G; Stolina M; Bolon B; Middleton S; Adlam M; Brown H; Zhu L; Feige U; Zack DJ
Arthritis Rheum; 2005 Oct; 52(10):3192-201. PubMed ID: 16200623
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity.
High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM
J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma: altered CD4/CD8 ratio in bone marrow.
Redoglia V; Boccadoro M; Battaglio S; Dianzani U; Massaia M; Pileri A
Haematologica; 1990; 75(2):129-31. PubMed ID: 2113506
[TBL] [Abstract][Full Text] [Related]
13. Quantitation and kinetics of polymorphonuclear leukocyte and lymphocyte accumulation in joints during adjuvant arthritis in the rat.
Issekutz AC; Issekutz TB
Lab Invest; 1991 May; 64(5):656-63. PubMed ID: 2030580
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis.
Lories RJ; Derese I; Luyten FP
Rheumatology (Oxford); 2008 May; 47(5):605-8. PubMed ID: 18334523
[TBL] [Abstract][Full Text] [Related]
15. Jaw bone changes in rats after treatment with zoledronate and pamidronate.
Senel FC; Kadioglu Duman M; Muci E; Cankaya M; Pampu AA; Ersoz S; Gunhan O
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):385-91. PubMed ID: 20060339
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease.
Strassle BW; Mark L; Leventhal L; Piesla MJ; Jian Li X; Kennedy JD; Glasson SS; Whiteside GT
Osteoarthritis Cartilage; 2010 Oct; 18(10):1319-28. PubMed ID: 20633675
[TBL] [Abstract][Full Text] [Related]
17. Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: an effect independent of an anti-angiogenic action.
Issekutz AC; Sapru K
Int Immunopharmacol; 2008 May; 8(5):708-16. PubMed ID: 18387513
[TBL] [Abstract][Full Text] [Related]
18. Do non-steroidal anti-inflammatory drugs influence chronic inflammation? The effects of piroxicam on chronic antigen-induced arthritis in rats.
Sigurdardottir SL; Freysdottir J; Vikingsdottir T; Valdimarsson H; Vikingsson A
Scand J Rheumatol; 2008; 37(6):469-76. PubMed ID: 19005999
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
20. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF).
Chapman I; Greville H; Ebeling PR; King SJ; Kotsimbos T; Nugent P; Player R; Topliss DJ; Warner J; Wilson JW
Clin Endocrinol (Oxf); 2009 Jun; 70(6):838-46. PubMed ID: 18823395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
